Sun-Ji Park

6PUBLICATIONS
21CO-AUTHORS
Molecular targetsOptical technologyNeurology and neuromuscular diseasesMedical devicesAutonomic nervous system
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 15, 2026
Amphiregulin drives EGFR-dependent genome stability in colorectal cancer and represents a targetable vulnerability.

|Mar 12, 2025
Diabetic Retinopathy (DR): Mechanisms, Current Therapies, and Emerging Strategies.

Hyewon Seo, Sun-Ji Park, Minsoo Song

|Jul 27, 2024
Targeting Mitochondrial Dysfunction and Reactive Oxygen Species for Neurodegenerative Disease Treatment.

Eui-Hwan Choi, Mi-Hye Kim, Sun-Ji Park

|Oct 14, 2023
MANF stimulates autophagy and restores mitochondrial homeostasis to treat autosomal dominant tubulointerstitial kidney disease in mice.

Yeawon Kim, Chuang Li, Chenjian Gu

|Jul 02, 2023
TXNIP: A key protein in the cellular stress response pathway and a potential therapeutic target.

Eui-Hwan Choi, Sun-Ji Park

|Aug 22, 2022
Blocking CHOP-dependent TXNIP shuttling to mitochondria attenuates albuminuria and mitigates kidney injury in nephrotic syndrome.

Sun-Ji Park, Yeawon Kim, Chuang Li

Pageof 1

Frequent Collaborators

2 joint publications

Chuang Li

2 joint publications

Fumihiko Urano

2 joint publications

Ying Maggie Chen

2 joint publications

Eui-Hwan Choi